Please provide your email address to receive an email when new articles are posted on . Large language models can help ensure you are providing evidence-based care. Getting the right answer out of ...
The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with ...
(MENAFN- EIN Presswire) EINPresswire/ -- B&B Optometry has been officially recognized as the Best Optometrist in Corona, California (92882) for 2025 by BusinessRate, a respected organization that ...
CORONA, CA, UNITED STATES, January 5, 2026 / EINPresswire.com / — B&B Optometry has been officially recognized as the Best Optometrist in Corona, California (92882) for 2025 by BusinessRate, a ...
FDA authorizes compassionate use of urcosimod for neuropathic corneal pain, a condition that causes severe pain and ...
Nanoscope has received a new patent ( US Patent No. 12459977) from the US Patent and Trademark Office (USPTO) for the company’s Multi-Characteristic Opsin (MCO) technology platform as a novel and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results